2015 Product Security Report
Meeting the compliance deadlines of the Drug Supply Chain Security Act has the attention of many in biopharma product and brand security
Now, analytics for pharmacos on top of the Open Payments database
Streebo offers a free look at Sunshine Act data compiled by type, company and physician
Oncology is now a $100-billion global market, growing 6-8% annually over the next five years
IMS Institute report finds variations in access
NABP moves ahead with management of the '.pharmacy' domain name
General availability for applicants begins on June 3
When worlds collide: Grappling with the rising therapeutic value--and rising cost--of cancer drugs
As new cancer drugs with promising efficacy but brutal costs enter the market, providers, payers and manufacturers are strategizing new payment approaches
Compliance packaging vendors keep innovating
Heightened concern over adherence and product stability may win over more pharma clients
World's first physician-owned proton therapy unit goes online in Florida
Mevion's compact S250 unit bids to change the economics of radiation oncology
Mylan says no to a merger with Teva, and Perrigo says no to Mylan
Meanwhile, industry asset shuffling is at record levels
Rumblings of US pharma price controls flare up
Obama's Precision Medicines initiative could re-open the door
Clinical trial financials is something 'no one wants to talk about' says consulting firm
Use of state-of-the-art software, combined with benchmarking and active oversight, fills this gap
Accenture finds an industry turnaround in 'future value'
Novo Nordisk is tagged as the only 'high performer'
FDA approves a generic for Teva's Copaxone, bringing longstanding regulatory battles near an end
Sandoz is first on the market with the MS drug, currently worth around $3 billion in the US
US spending on drugs hit $373.9 billion in 2014, up 13.1%
Effect of the first full year of Obamacare was muted, although a record number of prescriptions were written
Cryoport expands the user base of its cryogenic shipping services
Company targets evolving regenerative medicine market
FedEx-TNT Express merger will expand healthcare logistics options
$4.8-billion deal follows UPS' failed effort in 2013
SureScripts expands its national e-prescribing network to include long-term care
Partners with EHR vendor PointClickCare to access 10,000 senior-care facilities in North America
TrialCard takes closer aim at market access solutions
Leading copay-coupon provider expands its patient services with private equity help
US Bioservices offers real-time pharmacy records to payers
Service closes the loop on managing specialty-pharmaceutical therapy regimens
New EMD Serono Specialty Digest finds 'site of care' management a top payer priority
Do you know your J codes?
HCPC announces its Compliance Package of the Year
AstraZeneca's Seroquel XR sample kit takes top honors
Rep access to physicians continues its downward slide
If the count of working sales reps is rising, who will those reps be able to visit?
OptumRx-Catamaran merger brings further consolidation to US pharma market
$12.8-billion acquisition will bring 1 billion precriptions/year under one PBM's management
H. D. Smith reorganizes, expands upper management
Creation of a holding company streamlines future acquisitions; focus is on specialty drug services
'Dot-pharmacy' domain name is open for business at NABP
National association wins oversight for the valuable top-level domain (TLD), begins approving online pharmacies' use of it
Veeva Systems enlarges its stake in customer master data management (MDM)
Veeva OpenKey database service will provide a standardized quality level for global healthcare-provider reference data
Marken opens a Shanghai branch office for clinical logistics
Office will serve Shanghai and Suzhou life sciences clients
DSCSA compliance is forging ahead, says RxTrace survey
But a majority of dispensers (pharmacies) are not yet preparing for their July 1 deadline
Magellan Rx Management's annual report on medical pharmacy trend: up less than 10% in 2013
Top 25 medical-benefit drugs showed an 8% increase over prior year
Battle line sharpens with latest Express Scripts Drug Trend Report
Besides specialty pharmaceutical pricing, the cost of compounded drugs is highlighted
Reltio targets pharma sales and marketing with 'data as a service'
Company wins $10 million in venture capital as it lines up key life sciences service providers
